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Several lines of research provide strong evidence for a central role of amyloid-beta 
(Abeta) oligomers in the pathogenesis of Alzheimer's disease. Investigations on 
Abeta oligomer interference, however, are impeded by the lack of a quantitative 
assay to measure substance-induced effects on Abeta oligomers. We have 
developed a comprehensive, fast and reliable in vitro assay to quantify the removal of 
Abeta oligomers by any potential drug, for example D3 and its dimeric form, 
denominated D3D3. This multivalent D3 molecule was expected to have enhanced 
efficacy due to increased avidity. Therefore we wanted to investigate if there is a 
correlation between the removal of Abeta oligomers by D3 and D3D3 and positive 
effects on cognitive and motoric performance in transgenic AD animal models. 
